14-50138716-C-T

Variant summary

Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_006939.4(SOS2):​c.2854G>A​(p.Asp952Asn) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000279 in 1,349,748 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.00033 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00027 ( 0 hom. )

Consequence

SOS2
NM_006939.4 missense

Scores

1
3
15

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 7.48
Variant links:
Genes affected
SOS2 (HGNC:11188): (SOS Ras/Rho guanine nucleotide exchange factor 2) This gene encodes a regulatory protein that is involved in the positive regulation of ras proteins. Mutations in this gene are associated with Noonan Syndrome-9. [provided by RefSeq, Jul 2016]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.033882886).
BP6
Variant 14-50138716-C-T is Benign according to our data. Variant chr14-50138716-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 542404.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-50138716-C-T is described in Lovd as [Likely_benign].
BS2
High AC in GnomAd4 at 50 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
SOS2NM_006939.4 linkc.2854G>A p.Asp952Asn missense_variant 18/23 ENST00000216373.10 NP_008870.2 Q07890-1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
SOS2ENST00000216373.10 linkc.2854G>A p.Asp952Asn missense_variant 18/231 NM_006939.4 ENSP00000216373.5 Q07890-1
SOS2ENST00000543680.5 linkc.2755G>A p.Asp919Asn missense_variant 17/221 ENSP00000445328.1 Q07890-2

Frequencies

GnomAD3 genomes
AF:
0.000330
AC:
50
AN:
151468
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000146
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00158
Gnomad ASJ
AF:
0.00115
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00955
Gnomad NFE
AF:
0.000177
Gnomad OTH
AF:
0.000479
GnomAD3 exomes
AF:
0.000317
AC:
72
AN:
227036
Hom.:
0
AF XY:
0.000275
AC XY:
34
AN XY:
123490
show subpopulations
Gnomad AFR exome
AF:
0.0000704
Gnomad AMR exome
AF:
0.00119
Gnomad ASJ exome
AF:
0.00125
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000181
Gnomad OTH exome
AF:
0.000935
GnomAD4 exome
AF:
0.000272
AC:
326
AN:
1198164
Hom.:
0
Cov.:
17
AF XY:
0.000267
AC XY:
162
AN XY:
607174
show subpopulations
Gnomad4 AFR exome
AF:
0.0000367
Gnomad4 AMR exome
AF:
0.00124
Gnomad4 ASJ exome
AF:
0.00134
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000230
Gnomad4 OTH exome
AF:
0.000608
GnomAD4 genome
AF:
0.000330
AC:
50
AN:
151584
Hom.:
0
Cov.:
32
AF XY:
0.000311
AC XY:
23
AN XY:
74034
show subpopulations
Gnomad4 AFR
AF:
0.000145
Gnomad4 AMR
AF:
0.00158
Gnomad4 ASJ
AF:
0.00115
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000177
Gnomad4 OTH
AF:
0.000474
Alfa
AF:
0.000372
Hom.:
0
Bravo
AF:
0.000419
ExAC
AF:
0.000288
AC:
35

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Noonan syndrome 9 Benign:2
Benign, criteria provided, single submitterclinical testingGenome-Nilou Lab-- -
Likely benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 22, 2024- -
not specified Benign:1
Benign, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpApr 08, 2021Variant summary: SOS2 c.2854G>A (p.Asp952Asn) results in a conservative amino acid change located in the Ras guanine-nucleotide exchange factors catalytic domain (IPR001895) of the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.00032 in 227036 control chromosomes, predominantly at a frequency of 0.0012 within the Latino subpopulation in the gnomAD database. The observed variant frequency within Latino control individuals in the gnomAD database is approximately 480-fold of the estimated maximal expected allele frequency for a pathogenic variant in SOS2 causing Noonan Syndrome And Related Conditions phenotype (2.5e-06), strongly suggesting that the variant is a benign polymorphism found primarily in populations of Latino origin. c.2854G>A has been reported in the literature in an individual affected with RASopathy disorder and was described by the authors as "Likely disease-unrelated" (Cordeddu_2015), while it was also detected in another RASopathy-like sample co-occurring with a pathogenic variant (RAF1 c.770C>T, p.Ser257Leu; Castellanos_2020). Furthermore, the variant was detected in a case with metachondromatosis (Bowen_2011) and it was also detected in unaffected controls without Noonan Syndrome phenotype (Yamamoto_2015). These reports do not support association of the variant with Noonan Syndrome and Related Conditions. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. A ClinVar submitter (evaluation after 2014) cites the variant as likely benign. Based on the evidence outlined above, the variant was classified as benign. -
not provided Benign:1
Benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenJul 01, 2022SOS2: BS1, BS2 -
SOS2-related disorder Benign:1
Likely benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesMar 26, 2021This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Cardiovascular phenotype Benign:1
Benign, criteria provided, single submitterclinical testingAmbry GeneticsNov 20, 2019This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Noonan syndrome and Noonan-related syndrome Benign:1
Benign, criteria provided, single submitterclinical testingGenome Diagnostics Laboratory, The Hospital for Sick ChildrenSep 25, 2020- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.52
T
BayesDel_noAF
Benign
-0.55
CADD
Uncertain
25
DANN
Uncertain
1.0
DEOGEN2
Benign
0.23
T;.
Eigen
Benign
-0.039
Eigen_PC
Benign
0.22
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.89
D;D
M_CAP
Benign
0.0093
T
MetaRNN
Benign
0.034
T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.0
N;.
PrimateAI
Uncertain
0.63
T
PROVEAN
Benign
-1.1
N;N
REVEL
Benign
0.081
Sift
Benign
0.12
T;T
Sift4G
Benign
0.23
T;T
Polyphen
0.0
B;.
Vest4
0.33
MVP
0.30
MPC
0.19
ClinPred
0.047
T
GERP RS
5.6
Varity_R
0.15
gMVP
0.31

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs200387871; hg19: chr14-50605434; API